Search results
Oct 19, 2022 · Today, we’re pleased to announce our completed acquisition of Zymergen. This is our largest acquisition to date! It’s expected to significantly enhance our platform by integrating strong automation and software capabilities as well as providing a wealth of experience across diverse biological engineering approaches.
Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.
Oct 13, 2021 · The company behind the ad was Zymergen, a California synthetic biology company that had just gone public with a market capitalization of $3 billion. Its three founders — Josh Hoffman, Zach ...
Jul 25, 2022 · Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace.
Jul 25, 2022 · Zymergen aimed to leave its well-publicized woes behind through a new-year transformation into a biotech. Now, the company has been picked up by Ginkgo Bioworks, which will look for “strategic...
Oct 19, 2022 · BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that...
Apr 22, 2021 · Zymergen’s Hyaline product is a bio-based polymer film that is transparent and strong, yet bendable, making it good for use in foldable touchscreen phones, high-density flexible printed...
Jul 25, 2022 · Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its Foundry, including Zymergen's machine learning and data...
Jan 10, 2022 · By combining next-gen sequencing with proprietary machine learning and informatics, Zymergen’s platform transforms the search for structurally novel bioactive molecules from tedious screening...
Nov 22, 2021 · Rebounding from the 16% slide that they experienced last week, shares of Zymergen are soaring today as investors learn of an insider's significant acquisition of the company's stock.
